Evidence map›Paper›PMID 25414039›Full record

Trial reportBrain : a journal of neurology2015

Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity.

André Schmidt, Marc Walter, Hana Gerber, Erich Seifritz, Rudolf Brenneisen, Gerhard A Wiesbeck, Anita Riecher-Rössler, Undine E Lang, Stefan Borgwardt

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Brain : a journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.Annals of depression and anxiety · 2023
    Article
  4. Article
  5. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.The international journal of neuropsychopharmacology · 2018
    Article
  6. Article
  7. Neuroimaging the Effectiveness of Substance Use Disorder Treatments.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

André Schmidt1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 2 Medical Image Analysis Center, University Hospital Basel, Schanzenstrasse 55, 4031 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland andre.schmidt@unibas.ch.
Marc Walter1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland.
Hana Gerber1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland.
Erich Seifritz4 Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, 8032 Zurich, Switzerland.
Rudolf Brenneisen5 Department of Clinical Research (DCR), University of Bern, 3010 Bern, Switzerland.
Gerhard A Wiesbeck1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland.
Anita Riecher-Rössler1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland.
Undine E Lang1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland.
Stefan Borgwardt1 Department of Psychiatry (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4012 Basel, Switzerland 2 Medical Image Analysis Center, University Hospital Basel, Schanzenstrasse 55, 4031 Basel, Switzerland 3 Department of Clinical Research (DFK), University of Basel, Basel, Switzerland 6 Department of Psychosis Studies, Institute of Psychiatry, King's College London, De Crespigny Park 16, SE58AF London, UK.
University of Basel · CHKing's College London · GBUniversity Hospital of Zurich · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has shown that a single maintenance dose of heroin attenuates psychophysiological stress responses in heroin-dependent patients, probably reflecting the effectiveness of heroin-assisted therapies for the treatment of severe heroin addiction. However, the underlying neural circuitry of these effects has not yet been investigated. Using a cross-over, double-blind, vehicle-controlled design, 22 heroin-dependent and heroin-maintained outpatients from the Centre of Substance Use Disorders at the University Hospital of Psychiatry in Basel were studied after heroin and placebo administration, while 17 healthy controls from the general population were included for placebo administration only. Functional magnetic resonance imaging was used to detect brain responses to fearful faces and dynamic causal modelling was applied to compute fear-induced modulation of connectivity within the emotional face network. Stress responses were assessed by hormone releases and subjective ratings. Relative to placebo, heroin acutely reduced the fear-induced modulation of connectivity from the left fusiform gyrus to the left amygdala and from the right amygdala to the right orbitofrontal cortex in dependent patients. Both of these amygdala-related connectivity strengths were significantly increased in patients after placebo treatment (acute withdrawal) compared to healthy controls, whose connectivity estimates did not differ from those of patients after heroin injection. Moreover, we found positive correlations between the left fusiform gyrus to amygdala connectivity and different stress responses, as well as between the right amygdala to orbitofrontal cortex connectivity and levels of craving. Our findings indicate that the increased amygdala-related connectivity during fearful face processing after the placebo treatment in heroin-dependent patients transiently normalizes after acute heroin maintenance treatment. Furthermore, this study suggests that the assessment of amygdala-related connectivity during fear processing may provide a prognostic tool to assess stress levels in heroin-dependent patients and to quantify the efficacy of maintenance treatments in drug addiction.

Indexed as

Adrenocorticotropic HormoneAdultAmygdalaAnalgesics, OpioidBayes TheoremBrainDouble-Blind MethodFearFemaleHeroinHeroin DependenceHumansMaleMiddle AgedModels, NeurologicalStress, PsychologicalAdrenocorticotropic HormoneAnalgesics, OpioidHeroinacute heroin treatmentamygdala connectivityfunctional MRIheroin maintenancestress

Identifiers

PMID25414039
PMCPMC4285192
OpenAlexW2159611279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.